INMB
INmune Bio Inc
2.00$
+0.0%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -34.9% | -50.0% | -100.0% | – | – | – | -100.0% | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | +100.0% | -7.1% | – | – | |
| – | -34.9% | -50.0% | – | – | – | – | – | – | – | – | – | – | |
| – | +0.4% | +44.7% | -18.9% | +42.7% | -27.0% | +3.9% | -24.0% | -15.8% | -52.3% | +56.3% | -77.9% | – | |
| – | -7.2% | -2.6% | +18.5% | -19.9% | -12.0% | +18.6% | -5.1% | +15.8% | +23.5% | -31.0% | +5.0% | – | |
| – | -1.9% | +31.2% | -10.6% | +24.5% | -22.9% | +5.2% | +146.8% | -69.7% | -27.1% | +6.3% | -74.4% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | -174.3% | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | -10,262.2% | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.